AAAAAA

   
Results: 1-8 |
Results: 8
OPPORTUNISTIC INFECTION AND IMMUNOLOGICAL FUNCTION IN PATIENTS WITH HUMAN-IMMUNODEFICIENCY-VIRUS - ASSOCIATED NON-HODGKINS-LYMPHOMA TREATEDWITH CHEMOTHERAPY
Authors: SPARANO JA HU XP WIERNIK PH SARTA C REDDY DM HANAU L HENRY DH
Citation: Ja. Sparano et al., OPPORTUNISTIC INFECTION AND IMMUNOLOGICAL FUNCTION IN PATIENTS WITH HUMAN-IMMUNODEFICIENCY-VIRUS - ASSOCIATED NON-HODGKINS-LYMPHOMA TREATEDWITH CHEMOTHERAPY, Journal of the National Cancer Institute, 89(4), 1997, pp. 301-307
OPPORTUNISTIC INFECTION AND IMMUNOLOGICAL FUNCTION IN PATIENTS WITH AIDS-ASSOCIATED LYMPHOMA TREATED WITH CHEMOTHERAPY
Authors: SPARANO JA HU XP WIERNIK PH SARTA C REDDY D HANAU L
Citation: Ja. Sparano et al., OPPORTUNISTIC INFECTION AND IMMUNOLOGICAL FUNCTION IN PATIENTS WITH AIDS-ASSOCIATED LYMPHOMA TREATED WITH CHEMOTHERAPY, Journal of acquired immune deficiency syndromes and human retrovirology, 14(4), 1997, pp. 87-87
INFUSIONAL CYCLOPHOSPHAMIDE, DOXORUBICIN, AND ETOPOSIDE (CDE) FOR HIV-ASSOCIATED NON-HODGKINS-LYMPHOMA (NHL) - LONG-TERM FOLLOW-UP AND ANALYSIS OF PROGNOSTIC FACTORS
Authors: SPARANO JA WIERNIK PH HU XP SARTA C DOMENECH G CIOCZEK H RACEVSKIS J
Citation: Ja. Sparano et al., INFUSIONAL CYCLOPHOSPHAMIDE, DOXORUBICIN, AND ETOPOSIDE (CDE) FOR HIV-ASSOCIATED NON-HODGKINS-LYMPHOMA (NHL) - LONG-TERM FOLLOW-UP AND ANALYSIS OF PROGNOSTIC FACTORS, Journal of acquired immune deficiency syndromes and human retrovirology, 14(4), 1997, pp. 88-88
PHASE-I TRIAL OF HIGH-DOSE MITOXANTRONE PLUS CYCLOPHOSPHAMIDE AND FILGRASTIM IN PATIENTS WITH ADVANCED BREAST-CARCINOMA
Authors: SPARANO JA ROBERT N SILVERMAN P LAZARUS H MALIK U VENKATRAJ U SARTA C
Citation: Ja. Sparano et al., PHASE-I TRIAL OF HIGH-DOSE MITOXANTRONE PLUS CYCLOPHOSPHAMIDE AND FILGRASTIM IN PATIENTS WITH ADVANCED BREAST-CARCINOMA, Journal of clinical oncology, 14(9), 1996, pp. 2576-2583
PILOT TRIAL OF INFUSIONAL CYCLOPHOSPHAMIDE, DOXORUBICIN, AND ETOPOSIDE PLUS DIDANOSINE AND FILGRASTIM IN PATIENTS WITH HUMAN IMMUNODEFICIENCY VIRUS-ASSOCIATED NON-HODGKINS-LYMPHOMA
Authors: SPARANO JA WIERNIK PH HU XP SARTA C SCHWARTZ EL SOEIRO R HENRY DH MASON B RATECH H DUTCHER JP
Citation: Ja. Sparano et al., PILOT TRIAL OF INFUSIONAL CYCLOPHOSPHAMIDE, DOXORUBICIN, AND ETOPOSIDE PLUS DIDANOSINE AND FILGRASTIM IN PATIENTS WITH HUMAN IMMUNODEFICIENCY VIRUS-ASSOCIATED NON-HODGKINS-LYMPHOMA, Journal of clinical oncology, 14(11), 1996, pp. 3026-3035
DIDANOSINE (DDI) AMELIORATES NEUTROPENIA AND THROMBOCYTOPENIA IN PATIENTS WITH HIV-ASSOCIATED NON-HODGKINS-LYMPHOMA (NHL) TREATED WITH INFUSIONAL CYCLOPHOSPHAMIDE (C), DOXORUBICIN (D), AND ETOPOSIDE (E) PLUS GRANULOCYTE-COLONY-STIMULATING FACTOR (G-CSF)
Authors: SPARANO JA WIERNIK PH HU X DUTCHER JP SARTA C HENRY D MASON B
Citation: Ja. Sparano et al., DIDANOSINE (DDI) AMELIORATES NEUTROPENIA AND THROMBOCYTOPENIA IN PATIENTS WITH HIV-ASSOCIATED NON-HODGKINS-LYMPHOMA (NHL) TREATED WITH INFUSIONAL CYCLOPHOSPHAMIDE (C), DOXORUBICIN (D), AND ETOPOSIDE (E) PLUS GRANULOCYTE-COLONY-STIMULATING FACTOR (G-CSF), Blood, 86(10), 1995, pp. 3724-3724
INFUSIONAL CYCLOPHOSPHAMIDE, DOXORUBICIN AND ETOPOSIDE IN HIV-RELATEDNON-HODGKINS-LYMPHOMA - A FOLLOW-UP REPORT OF A HIGHLY-ACTIVE REGIMEN
Authors: SPARANO JA WIERNIK PH STRACK M LEAF A BECKER NH SARTA C CARNEY D ELKIND R SHAH M VALENTINE ES DUTCHER JP
Citation: Ja. Sparano et al., INFUSIONAL CYCLOPHOSPHAMIDE, DOXORUBICIN AND ETOPOSIDE IN HIV-RELATEDNON-HODGKINS-LYMPHOMA - A FOLLOW-UP REPORT OF A HIGHLY-ACTIVE REGIMEN, Leukemia & lymphoma, 14(3-4), 1994, pp. 263-271
INFUSIONAL CYCLOPHOSPHAMIDE-(C), DOXORUBICIN-(D), AND ETOPOSIDE-(E) IN HIV-RELATED NON-HODGKINS-LYMPHOMA (NHL) - A FOLLOW-UP REPORT OF A HIGHLY-ACTIVE REGIMEN
Authors: SPARANO JA WIERNIK PH DUTCHER JP SARTA C STRACK M LEAF A
Citation: Ja. Sparano et al., INFUSIONAL CYCLOPHOSPHAMIDE-(C), DOXORUBICIN-(D), AND ETOPOSIDE-(E) IN HIV-RELATED NON-HODGKINS-LYMPHOMA (NHL) - A FOLLOW-UP REPORT OF A HIGHLY-ACTIVE REGIMEN, Blood, 82(10), 1993, pp. 10000386-10000386
Risultati: 1-8 |